Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Biorxiv : the Preprint Server for Biology
|
September 11, 2024
Neuroendocrine Prostate Cancer Drivers SOX2 and BRN2 Confer Differential Responses to Imipridones ONC201, ONC206, and ONC212 in Prostate Cancer Cell Lines
Connor Purcell, Praveen R Srinivasan, Maximilian Pinho-Schwermann, et al.
American Journal of Translational Research
|
January 17, 2025
Neuroendocrine prostate cancer drivers SOX2 and BRN2 confer differential responses to imipridones ONC201, ONC206, and ONC212 in prostate cancer cell lines
Connor Purcell, Praveen R Srinivasan, Maximilian Pinho-Schwermann, et al.
Cancers
|
February 13, 2025
Heterogeneity in Cancer
William J MacDonald, Connor Purcell, Maximilian Pinho-Schwermann, et al.
American Journal of Cancer Research
|
October 17, 2024
Synergistic anti-tumor activity, reduced pERK, and immuno-stimulatory cytokine profiles with 5-FU or ONC212 plus KRAS G12D inhibitor MRTX1133 in CRC and pancreatic cancer cells independent of G12D mutation
Vida Tajiknia, Maximilian Pinho-Schwermann, Praveen R Srinivasan, et al.
American Journal of Cancer Research
|
January 12, 2026
Inhibition of ITGB6 stimulates potent anti-tumor responses in immunocompetent mouse models of head and neck squamous cell carcinoma and pancreatic adenocarcinoma
William J MacDonald, Praveen R Srinivasan, Maximilian Pinho-Schwermann, et al.
American Journal of Cancer Research
|
January 13, 2025
Synergistic combination therapy with ONC201 or ONC206, and enzalutamide or darolutamide in preclinical studies of castration-resistant prostate cancer
Laura Jinxuan Wu, Maximilian Pinho-Schwermann, Lanlan Zhou, et al.
Transplantation Proceedings
|
November 1, 2019
Liver Transplantation for Non-hepatocellular Carcinoma Malignancy: A Single-Center Experience
Alessandra Maria Mont Alverne Pierre, Camila Monteiro Veras, Ticiana Mota Esmeraldo, et al.
Journal of Clinical Medicine
|
November 3, 2018
Angiopoietin-2: A Potential Mediator of the Glycocalyx Injury in Adult Nephrotic Patients
Maria Moura Santana Chaves, Matheus de Souza Mendes, Maximilian Pinho Schwermann, et al.
Cancer Treatment Reviews
|
December 2, 2025
Cellular senescence: A novel mechanism of therapeutic resistance in prostate cancer
Claire Lin, Matthew J Hadfield, Amol Rathore, et al.
The Journal of Clinical Investigation
|
July 15, 2025
Corrigendum to Targeting apoptotic pathways for cancer therapy
Xiaobing Tian, Praveen R Srinivasan, Vida Tajiknia, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Biorxiv : the Preprint Server for Biology
|
September 11, 2024
Neuroendocrine Prostate Cancer Drivers SOX2 and BRN2 Confer Differential Responses to Imipridones ONC201, ONC206, and ONC212 in Prostate Cancer Cell Lines
Connor Purcell, Praveen R Srinivasan, Maximilian Pinho-Schwermann, et al.
American Journal of Translational Research
|
January 17, 2025
Neuroendocrine prostate cancer drivers SOX2 and BRN2 confer differential responses to imipridones ONC201, ONC206, and ONC212 in prostate cancer cell lines
Connor Purcell, Praveen R Srinivasan, Maximilian Pinho-Schwermann, et al.
Cancers
|
February 13, 2025
Heterogeneity in Cancer
William J MacDonald, Connor Purcell, Maximilian Pinho-Schwermann, et al.
American Journal of Cancer Research
|
October 17, 2024
Synergistic anti-tumor activity, reduced pERK, and immuno-stimulatory cytokine profiles with 5-FU or ONC212 plus KRAS G12D inhibitor MRTX1133 in CRC and pancreatic cancer cells independent of G12D mutation
Vida Tajiknia, Maximilian Pinho-Schwermann, Praveen R Srinivasan, et al.
American Journal of Cancer Research
|
January 12, 2026
Inhibition of ITGB6 stimulates potent anti-tumor responses in immunocompetent mouse models of head and neck squamous cell carcinoma and pancreatic adenocarcinoma
William J MacDonald, Praveen R Srinivasan, Maximilian Pinho-Schwermann, et al.
American Journal of Cancer Research
|
January 13, 2025
Synergistic combination therapy with ONC201 or ONC206, and enzalutamide or darolutamide in preclinical studies of castration-resistant prostate cancer
Laura Jinxuan Wu, Maximilian Pinho-Schwermann, Lanlan Zhou, et al.
Transplantation Proceedings
|
November 1, 2019
Liver Transplantation for Non-hepatocellular Carcinoma Malignancy: A Single-Center Experience
Alessandra Maria Mont Alverne Pierre, Camila Monteiro Veras, Ticiana Mota Esmeraldo, et al.
Journal of Clinical Medicine
|
November 3, 2018
Angiopoietin-2: A Potential Mediator of the Glycocalyx Injury in Adult Nephrotic Patients
Maria Moura Santana Chaves, Matheus de Souza Mendes, Maximilian Pinho Schwermann, et al.
Cancer Treatment Reviews
|
December 2, 2025
Cellular senescence: A novel mechanism of therapeutic resistance in prostate cancer
Claire Lin, Matthew J Hadfield, Amol Rathore, et al.
The Journal of Clinical Investigation
|
July 15, 2025
Corrigendum to Targeting apoptotic pathways for cancer therapy
Xiaobing Tian, Praveen R Srinivasan, Vida Tajiknia, et al.
Page
of 2